The S&P BSE Healthcare is designed to provide investors with a benchmark reflecting companies included in the S&P BSE AllCap that are classified as members of the healthcare sector.
Due to the ongoing coronavirus pandemic, the pharma companies shares stand to gain in the coming year. Since March, the pharma indexes have rallied. The world is eagerly hoping for a cure for the dreaded coronavirus and all eyes are on the pharma companies to come up with a suitable drug and vaccination. This has led to the pharma companies doing really well after a very long time.
Pharma stocks have rallied like never before. Take a look at S&P BSE Healthcare Index. It’s 52 week low was 10,947.99 and High 16,324.87.
So this is a time to relook at your portfolio once again. Take KAUTILYA’s expert guidance in order to buy premium pharma stocks that will help you create medium to long term benefits.
KAUTILYA brings the best of #stocks, investing and trading advice! Are you with us to build security and wealth? Follow our page for daily updates and tag your friends with free advice! Call us today at 8078767676 to know more!